Kwak K, Akkaya M, Pierce SK. B cell signaling in context. Nat Immunol. 2019. https://doi.org/10.1038/s41590-019-0427-9.

Article  PubMed  Google Scholar 

Herzog S, Reth M, Jumaa H. Regulation of B-cell proliferation and differentiation by pre-B-cell receptor signalling. Nat Rev Immunol. 2009;9(3):195–205. https://doi.org/10.1038/nri2491.

Article  PubMed  CAS  Google Scholar 

Nemazee D. Receptor editing in lymphocyte development and central tolerance. Nat Rev Immunol. 2006;6(10):728–40. https://doi.org/10.1038/nri1939.

Article  PubMed  CAS  Google Scholar 

Nemazee D. Mechanisms of central tolerance for B cells. Nat Rev Immunol. 2017;17(5):281–94. https://doi.org/10.1038/nri.2017.19.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Tull TJ, Pitcher MJ, Guesdon W, et al. Human marginal zone B cell development from early T2 progenitors. J Exp Med. 2021;218(4):e20202001. https://doi.org/10.1084/jem.20202001.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Cyster JG, Allen CDC. B cell responses cell interaction dynamics and decisions. Cell. 2019. https://doi.org/10.1016/j.cell.2019.03.016.

Article  PubMed  PubMed Central  Google Scholar 

Rawlings DJ, Metzler G, Wray-Dutra M, Jackson SW. Altered B cell signalling in autoimmunity. Nat Rev Immunol. 2017;17(7):421–36. https://doi.org/10.1038/nri.2017.24.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Tsokos GC, Lo MS, Reis PC, Sullivan KE. New insights into the immunopathogenesis of systemic lupus erythematosus. Nat Rev Rheumatol. 2016;12(12):716–30. https://doi.org/10.1038/nrrheum.2016.186.

Article  PubMed  CAS  Google Scholar 

Leffler J, Martin M, Gullstrand B, et al. Neutrophil extracellular traps that are not degraded in systemic lupus erythematosus activate complement exacerbating the disease. J Immunol. 2012;188(7):3522–31. https://doi.org/10.4049/jimmunol.1102404.

Article  PubMed  CAS  Google Scholar 

Crow MK, Olferiev M, Kirou KA. Type I interferons in autoimmune disease. Annu Rev Pathol Mech Dis. 2019;14(1):369–93. https://doi.org/10.1146/annurev-pathol-020117-043952.

Article  CAS  Google Scholar 

Giang S, La Cava A. Regulatory T cells in SLE biology and use in treatment. Curr Rheumatol Rep. 2016;18(11):67. https://doi.org/10.1007/s11926-016-0616-6.

Article  PubMed  CAS  Google Scholar 

Suárez-Fueyo A, Bradley SJ, Tsokos GC. T cells in systemic lupus erythematosus. Curr Opin Immunol. 2016;43:32–8. https://doi.org/10.1016/j.coi.2016.09.001.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Möckel T, Basta F, Weinmann-Menke J, Schwarting A. B cell activating factor (BAFF) structure, functions, autoimmunity and clinical implications in systemic lupus erythematosus (SLE). Autoimmun Rev. 2021;20(2):102736. https://doi.org/10.1016/j.autrev.2020.102736.

Article  PubMed  CAS  Google Scholar 

Parodis I, Rovin BH, Tektonidou MG, et al. Lupus nephritis. Nat Rev Dis Primer. 2025;11(1):69. https://doi.org/10.1038/s41572-025-00653-y.

Article  Google Scholar 

Parodis I, Nikolopoulos D, Brylid A, Hultgren O, Alarcón-Riquelme ME, Sjöwall C. Old and new autoantibodies in systemic lupus erythematosus. Expert Rev Clin Immunol. 2026;22(1):19–29. https://doi.org/10.1080/1744666X.2026.2625964.

Article  PubMed  CAS  Google Scholar 

Hahne M, Kataoka T, Schröter M, et al. APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth. J Exp Med. 1998;188(6):1185–90. https://doi.org/10.1084/jem.188.6.1185.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Mackay F, Woodcock SA, Lawton P, et al. Mice transgenic for Baff develop lymphocytic disorders along with autoimmune manifestations. J Exp Med. 1999;190(11):1697–710. https://doi.org/10.1084/jem.190.11.1697.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Schneider P, MacKay F, Steiner V, et al. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J Exp Med. 1999;189(11):1747–56. https://doi.org/10.1084/jem.189.11.1747.

Article  PubMed  PubMed Central  CAS  Google Scholar 

López‐Fraga M, Fernández R, Albar JP, Hahne M. Biologically active APRIL is secreted following intracellular processing in the Golgi apparatus by furin convertase. EMBO Rep. 2001;2(10):945–51. https://doi.org/10.1093/embo-reports/kve198.

Article  PubMed  PubMed Central  Google Scholar 

Nardelli B, Belvedere O, Roschke V, et al. Synthesis and release of B-lymphocyte stimulator from myeloid cells. Blood. 2001;97(1):198–204. https://doi.org/10.1182/blood.V97.1.198.

Article  PubMed  CAS  Google Scholar 

Huard B, Arlettaz L, Ambrose C, et al. BAFF production by antigen-presenting cells provides T cell co-stimulation. Int Immunol. 2004;16(3):467–75. https://doi.org/10.1093/intimm/dxh043.

Article  PubMed  CAS  Google Scholar 

Suzuki K, Setoyama Y, Yoshimoto K, Tsuzaka K, Abe T, Takeuchi T. Effect of interleukin-2 on synthesis of B cell activating factor belonging to the tumor necrosis factor family (BAFF) in human peripheral blood mononuclear cells. Cytokine. 2008;44(1):44–8. https://doi.org/10.1016/j.cyto.2008.06.005.

Article  PubMed  CAS  Google Scholar 

Liu Y, Xu L, Opalka N, Kappler J, Shu HB, Zhang G. Crystal structure of sTALL-1 reveals a virus-like assembly of TNF family ligands. Cell. 2002;108(3):383–94. https://doi.org/10.1016/S0092-8674(02)00631-1.

Article  PubMed  CAS  Google Scholar 

Cachero TG, Schwartz IM, Qian F, et al. Formation of virus-like clusters is an intrinsic property of the tumor necrosis factor family member BAFF (B cell activating factor). Biochemistry. 2006;45(7):2006–13. https://doi.org/10.1021/bi051685o.

Article  PubMed  CAS  Google Scholar 

Eslami M, Schneider P. Function, occurrence and inhibition of different forms of BAFF. Curr Opin Immunol. 2021. https://doi.org/10.1016/j.coi.2021.06.009.

Article  PubMed  Google Scholar 

Thien M, Phan TG, Gardam S, et al. Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches. Immunity. 2004;20(6):785–98. https://doi.org/10.1016/j.immuni.2004.05.010.

Article  PubMed  CAS  Google Scholar 

Boghdadi G, Elewa EA. Increased serum APRIL differentially correlates with distinct cytokine profiles and disease activity in systemic lupus erythematosus patients. Rheumatol Int. 2014;34(9):1217–23. https://doi.org/10.1007/s00296-014-3020-4.

Article  PubMed  CAS  Google Scholar 

Sari S, Cinar S, Yalcinkaya Y, et al. The relationship between serum A proliferation-inducing ligand and B-cell activating factor levels with disease activity and organ involvement in systemic lupus erythematosus. Lupus. 2022;31(5):555–64. https://doi.org/10.1177/09612033221086123.

Article  PubMed  CAS